Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nigella Sativa for Dyslipidemia in Elderly
NCT01531062Phase 2Completed
- Sponsor
- Universitas Indonesia
- Start
- Sep 2011
- Primary completion
- Dec 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in dyslipidemia comparing Nigella sativa with Placebo (2 arms). Primary endpoints: Total Cholesterol Level at 56 days, Low Density Lipoprotein Cholesterol Level at 56 days and 2 more. Started Sep 2011; status: completed.
02
Drugs
nigella sativa
03
Conditions
dyslipidemia
Beyond the preview
Go deeper on NCT01531062.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01531062.